Targeting the root cause of fibromyalgia—central sensitization in the brain—to reduce widespread pain, fatigue, and cognitive fog without systemic medications.
Fibromyalgia is a disorder of central sensitization—the brain amplifies pain signals. TMS targets the Motor Cortex to activate descending pain inhibition and "turn down the volume" on chronic pain.
Understanding why fibromyalgia is not "just pain"—it's the brain's pain processing system gone haywire.
Fibromyalgia is now understood as a disorder of central sensitization—the brain and spinal cord amplify pain signals, transforming normal sensory input into widespread, chronic pain. Unlike injuries where pain has a clear peripheral source, fibromyalgia pain originates from dysregulated neural processing in the central nervous system itself.
This central amplification explains the hallmark features of fibromyalgia: widespread musculoskeletal pain, allodynia (pain from normally non-painful stimuli), severe fatigue, "fibro fog" (cognitive impairment), and disrupted sleep. Standard pain medications often fail because they target peripheral pain pathways rather than the central root cause.
Neuroimaging studies confirm that fibromyalgia patients show hyperactivity in the brain's "pain matrix"—the thalamus, insula, and somatosensory cortex—even in response to minimal stimuli. TMS directly targets this central dysfunction.
Activating the brain's natural pain-suppression systems through targeted magnetic stimulation.
TMS for fibromyalgia primarily targets the Primary Motor Cortex (M1). High-frequency stimulation of M1 activates descending pain inhibitory pathways in the spinal cord—the body's built-in "pain brake system." In fibromyalgia, these inhibitory pathways are dysfunctional. TMS essentially restores their function, "dialing down" the amplified pain signals.
Additionally, we can simultaneously target the Dorsolateral Prefrontal Cortex (DLPFC) to address the comorbid depression, anxiety, and cognitive impairment that affect up to 80% of fibromyalgia patients. This dual-target approach treats the full syndrome—not just the pain—in a single course of therapy.
Precisely measuring your individual motor threshold to ensure stimulation intensity is optimized for pain relief without discomfort.
High-frequency rTMS to the Motor Cortex stimulates descending inhibitory pathways, systematically reducing central sensitization.
Over multiple sessions, TMS induces lasting neuroplastic changes—the brain "relearns" normal pain processing, providing sustained relief.
Targeting the central nervous system dysfunction behind every major fibromyalgia symptom.
Reducing the hyperactivity of the central pain matrix to diminish the all-over body aches and tender points.
Enhancing prefrontal cortex function to improve concentration, memory, and the mental clarity that chronic pain erodes.
Lifting the exhausting burden of constant pain processing, freeing energy for daily activities and improving overall vitality.
Improving sleep quality by reducing the cortical hyperarousal that prevents restorative deep sleep in fibromyalgia.
Directly treating the comorbid mood disorders that share neural pathways with chronic pain, breaking the pain-depression cycle.
Reducing the central sensitization that makes even light touch feel painful—restoring normal sensory perception.
| Feature | Standard Fibromyalgia Meds | TMS Therapy |
|---|---|---|
| Mechanism | Duloxetine/Pregabalin: systemic neurotransmitter modulation. | Directly activates descending pain inhibition from the Motor Cortex. |
| Common Side Effects | Weight gain, sedation, nausea, sexual dysfunction. | None systemic. Mild scalp sensation during treatment. |
| Cognitive Impact | Often worsens "fibro fog" (Pregabalin causes cognitive dulling). | Improves cognition via prefrontal stimulation. |
| Dependency Risk | Pregabalin has abuse potential; withdrawal symptoms common. | Zero dependency or withdrawal risk. |
Chronic pain and depression share the exact same neural pathways. We treat both simultaneously.
We stimulate the Motor Cortex (M1) for direct pain relief, and the Prefrontal Cortex (DLPFC) to address the debilitating depression and anxiety that accompany fibromyalgia.
We find your exact "motor threshold"—the precise magnetic intensity needed to activate your neurons—ensuring the treatment is both effective and comfortable.
Our goal is to provide enough central relief that patients can safely taper down reliance on Pregabalin, Duloxetine, and opioid medications—reducing side effects and improving quality of life.
Dr. Amin recognizes that fibromyalgia is far more than "just pain"—it's a complex brain-based condition that robs patients of their energy, clarity, and joy. By utilizing evidence-based TMS protocols targeting both the Motor Cortex and Prefrontal Cortex, he offers a path to relief for patients who have been failed by conventional medications.
Read Full BiographyHear from patients whose lives were transformed through Dr. Amin's care.
If medications haven't relieved your chronic pain and fatigue, it's time to explore cortical neuromodulation with Dr. Amin.
Non-invasive. Non-opioid. Discover how TMS can rewire your brain's pain amplifier and restore your quality of life.
Book Your Consultation Today